These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 21745517)

  • 1. Multiple dose vaccination with heterologous H5N2 vaccine: immune response and protection against variant clade 2.2.1 highly pathogenic avian influenza H5N1 in broiler breeder chickens.
    Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
    Vaccine; 2011 Aug; 29(37):6219-25. PubMed ID: 21745517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.
    Grund C; Abdelwhab el-SM; Arafa AS; Ziller M; Hassan MK; Aly MM; Hafez HM; Harder TC; Beer M
    Vaccine; 2011 Jul; 29(33):5567-73. PubMed ID: 21244859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1.
    Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
    Vet Microbiol; 2012 Feb; 155(1):13-20. PubMed ID: 21920677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of avian influenza H5N1 viral RNA in tissues of AI-vaccinated and unvaccinated contact chickens after experimental infection.
    Hassan MK; Kilany WH; Abdelwhab EM; Arafa AS; Selim A; Samy A; Samir M; Le Brun Y; Jobre Y; Aly MM
    Arch Virol; 2012 May; 157(5):951-9. PubMed ID: 22350650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus.
    Swayne DE; Lee CW; Spackman E
    Avian Pathol; 2006 Apr; 35(2):141-6. PubMed ID: 16595307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of H5 inactivated vaccines in meat turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus.
    Kilany WH; Abdelwhab EM; Arafa AS; Selim A; Safwat M; Nawar AA; Erfan AM; Hassan MK; Aly MM; Hafez HM
    Vet Microbiol; 2011 May; 150(1-2):28-34. PubMed ID: 21236607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inactivated H5N2 vaccine reduces transmission of highly pathogenic H5N1 avian influenza virus among native chickens.
    Poetri ON; Bouma A; Murtini S; Claassen I; Koch G; Soejoedono RD; Stegeman JA; van Boven M
    Vaccine; 2009 May; 27(21):2864-9. PubMed ID: 19428896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the protection induced by avian influenza vaccines containing a 1994 Mexican H5N2 LPAI seed strain against a 2008 Egyptian H5N1 HPAI virus belonging to clade 2.2.1 by means of serological and in vivo tests.
    Terregino C; Toffan A; Cilloni F; Monne I; Bertoli E; Castellanos L; Amarin N; Mancin M; Capua I
    Avian Pathol; 2010 Jun; 39(3):215-22. PubMed ID: 20544428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of high pathogenicity avian influenza virus in eggs from chickens once or twice vaccinated with an oil-emulsified inactivated H5 avian influenza vaccine.
    Swayne DE; Eggert D; Beck JR
    Vaccine; 2012 Jul; 30(33):4964-70. PubMed ID: 22652397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
    Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.
    Bhat S; Sood R; Shukla S; Khandia R; Pateriya AK; Kumar N; Singh VK; Kalaiyarasu S; Kumar M; Bhatia S
    Vet Microbiol; 2018 Apr; 217():149-157. PubMed ID: 29615248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of vaccination against highly pathogenic avian influenza is dramatically suppressed by early infection of chickens with reticuloendotheliosis virus.
    Sun S; Cui Z; Wang J; Wang Z
    Avian Pathol; 2009 Feb; 38(1):31-4. PubMed ID: 19145513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of vaccination on infection with Vietnam H5N1 high pathogenicity avian influenza virus in hens and the eggs they lay.
    Bertran K; Moresco K; Swayne DE
    Vaccine; 2015 Mar; 33(11):1324-30. PubMed ID: 25657093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia.
    Isoda N; Sakoda Y; Kishida N; Soda K; Sakabe S; Sakamoto R; Imamura T; Sakaguchi M; Sasaki T; Kokumai N; Ohgitani T; Saijo K; Sawata A; Hagiwara J; Lin Z; Kida H
    Arch Virol; 2008; 153(9):1685-92. PubMed ID: 18651092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine.
    Philippa J; Baas C; Beyer W; Bestebroer T; Fouchier R; Smith D; Schaftenaar W; Osterhaus A
    Vaccine; 2007 May; 25(19):3800-8. PubMed ID: 17403559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal 2 years field study of conventional vaccination against highly pathogenic avian influenza H5N1 in layer hens.
    Rudolf M; Pöppel M; Fröhlich A; Breithaupt A; Teifke J; Blohm U; Mettenleiter T; Beer M; Harder T
    Vaccine; 2010 Oct; 28(42):6832-40. PubMed ID: 20727963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
    Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
    Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.